November 20, 2018 (1:30 PM)
Pre-clinical mouse models and breast cancer organoids reveal clues to therapeutic resistance and disease progression
Kristina Havas
Metabolism, Epigenetics and Breast Cancer,
FIRC Institute for Molecular Oncology, IFOM Milan